Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Aina Martin(Health Research Institute of the Balearic Islands), Ernest Sala(Hospital Universitario Son Espases), Andreas Jahn(University of Washington), Cristina Villena(Hospital Universitario Son Espases), Carlos Río(Health Research Institute of the Balearic Islands), Linda Elowson(Lund University), Orlando Gigirey(Hospital Universitario Son Espases), Ángel Francisco Carvajal(Hospital Universitario Son Espases), María Molina‐Molina(Instituto de Salud Carlos III), Gunilla Westergren‐Thorsson(Lund University), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), J. Lluch Pons(Hospital Universitario Son Espases), Julio Velasco(Hospital Universitario Son Espases), Josep V. Mercader(Broad Institute), Amanda Iglesias(Health Research Institute of the Balearic Islands), Catalina Crespı́(Health Research Institute of the Balearic Islands)
Cited by 1
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
|Journal of Clinical Investigation|2009|556
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343